Malin Corporation PLC
ISEQ:MLC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Malin Corporation PLC
ISEQ:MLC
|
IE |
|
M
|
Mail.ru Group Ltd
OTC:MLRYY
|
CY |
|
China Feihe Ltd
HKEX:6186
|
CN |
|
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
US |
|
Just Eat Takeaway.com NV
AEX:TKWY
|
NL |
|
Fingerprint Cards AB
STO:FING B
|
SE |
|
Nedap NV
F:NE3
|
NL |
|
S
|
Sparx Technology Inc
XTSX:SPRX
|
CA |
|
Beijing United Information Technology Co Ltd
SSE:603613
|
CN |
|
Aditya Vision Ltd
BSE:540205
|
IN |
|
I
|
Israel Petrochemical Enterprises Ltd
TASE:PTCH
|
IL |
|
Rukun Raharja Tbk PT
IDX:RAJA
|
ID |
|
P
|
Planet 13 Holdings Inc
CNSX:PLTH
|
US |
Malin Corporation PLC
Malin Corp. Plc.invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. The company is headquartered in Dublin, Dublin and currently employs 5 full-time employees. The company went IPO on 2015-03-25. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, CG Oncology, Wren, KNOW Bio and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates, initially focused on the treatment of hematological malignancies, including multiple myeloma, and solid tumours, like prostate cancer. The company is also developing two CAR-T therapies: autologous and allogeneic. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder-saving therapeutics for patients with bladder cancer.
Malin Corp. Plc.invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. The company is headquartered in Dublin, Dublin and currently employs 5 full-time employees. The company went IPO on 2015-03-25. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, CG Oncology, Wren, KNOW Bio and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates, initially focused on the treatment of hematological malignancies, including multiple myeloma, and solid tumours, like prostate cancer. The company is also developing two CAR-T therapies: autologous and allogeneic. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder-saving therapeutics for patients with bladder cancer.
